Stocks Trading At 52-Week Low
As on Saturday, July 26, 11 stocks from the Russell 3000 are trading at their 52-week lows. Among these stocks, Sarepta Therapeutics (SRPT) has corrected the most in the last one month, falling by 32% over this period.
Stocks At 52W Lows
Below is the complete list of these stocks, sorted by market capitalization – highlighting some the headwinds for these stocks across industries ranging from Cable & Satellite and Single-Family Residential REITs to Property & Casualty Insurance and Specialty Chemicals:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| CHTR | $43.9 Bil | -18.5% | -18.9% | -22.3% | -3.2% |
| ELS | $11.4 Bil | -0.5% | -3.8% | -4.4% | -7.4% |
| RLI | $6.2 Bil | 0.0% | -3.5% | -4.9% | -2.8% |
| BCPC | $4.8 Bil | -0.3% | -2.6% | -5.8% | -16.7% |
| CRVL | $4.6 Bil | -0.8% | -5.0% | -13.6% | -10.0% |
| RHI | $4.0 Bil | -0.1% | -4.9% | -2.6% | -36.3% |
| WDFC | $2.9 Bil | -0.2% | -3.5% | -7.4% | -15.6% |
| LFST | $1.6 Bil | 0.0% | -1.9% | -16.4% | -25.7% |
| NVCR | $1.3 Bil | -4.0% | -24.8% | -30.5% | -35.9% |
| SRPT | $1.2 Bil | -7.4% | -15.2% | -31.7% | -91.9% |
| CRI | $0.9 Bil | -19.7% | -13.5% | -12.9% | -54.0% |
Tempted to buy some of these stocks at their current low? That would be a good idea if you are sure a particular stock has bottomed out. But it is a rather risky trade. In contrast, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.
- This Strategy Pays You 8.7% While Lining Up MPWR at Bargain Prices
- What Could Light a Fire Under Microsoft Stock
- 3 Key Risks That Could Drag Down Meta Platforms Stock
- Cash Machine Trading Cheap – Fiserv Stock Set to Run?
- Is Recursion Pharmaceuticals Stock Attractive?
- Comfort Systems USA Stock’s Winning Streak May Not Be Over Yet